Our molecules
Innovative small-molecule therapies targeting CNS disorders for patients.


NVL-19
Targeting neuroplasticity for enhanced cognitive function and recovery in Alzheimer's disease.


NVL-20
Developing treatments for MCI and early stage Alzheimer's disease.
Innovative Solutions for CNS Disorders
At NeuroVista Labs, we pioneer small-molecule TrkB agonists aimed at enhancing neuroplasticity and promoting brain repair in CNS diseases, redefining treatment possibilities for patients worldwide.
Commitment to Scientific Excellence
Transforming Neuroscience through Innovation
Our team is dedicated to advancing cutting-edge research and developing impactful therapies, fostering collaborations to optimize brain health and improve the quality of life for those suffering from neurological conditions.
Contact
Get in touch for partnership and inquiries.
info@neurovistalabs.com.br
+1 (786) 979-7926
© 2025. All rights reserved.
